Previous Article | Next Article 
J Virol, May 1998, p. 4224-4230, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Increased Misincorporation Fidelity Observed for Nucleoside
Analog Resistance Mutations M184V and E89G in Human Immunodeficiency
Virus Type 1 Reverse Transcriptase Does Not Correlate with the
Overall Error Rate Measured In Vitro
William C.
Drosopoulos and
Vinayaka R.
Prasad*
Department of Microbiology and Immunology,
Albert Einstein College of Medicine, Bronx, New York 10461
Received 9 December 1997/Accepted 29 January 1998
 |
ABSTRACT |
Nucleoside analog-resistant variants of human immunodeficiency
virus type 1 (HIV-1) reverse transcriptase (RT) that displayed higher
in vitro polymerase fidelity were previously identified via nucleotide
insertion and mispair extension assays. To evaluate the contribution of
increased nucleotide insertion and primer extension fidelities on the
overall error rate of HIV-1 RT, we have measured the impact of two such
mutations, E89G and M184V, on DNA copying fidelity in an M13
phage-based forward mutation assay. Using this assay, we observed
mutation frequencies of 8.60 × 10
3, 6.26 × 10
3, 5.53 × 10
3, and 12.30 × 10
3 for wild-type, E89G, M184V, and double-mutant
E89G/M184V HIV-1 RTs, respectively. Therefore, the overall polymerase
fidelities of wild-type, E89G, M184V, and E89G/M184V HIV-1 RTs are
similar (less than twofold differences) for DNA-dependent DNA
synthesis. Thus, rather large increases in fidelity of deoxynucleoside
triphosphate insertion and mispair extension observed previously appear
not to influence the overall error rate of these mutants. However, a
qualitative analysis of the mutations induced revealed significant differences in the mutational spectra between the wild-type and mutant
enzymes.
 |
INTRODUCTION |
One of the obstacles to successful
antiretroviral treatment of human immunodeficiency virus (HIV)
infections is the eventual emergence of drug-resistant viruses. A
primary contributor to this process is the inherently high genetic
variability of HIV, commonly encountered in virus populations in the
infected individuals (9, 19, 25). This high level of
variability is directly related to the viral mutation rate which, in
turn, is thought to be significantly influenced by the polymerase
fidelity of HIV reverse transcriptase (RT).
Mutants of HIV type 1 (HIV-1) RT resistant to nucleoside analog drugs
that coincidentally display higher in vitro polymerase fidelity in
gel-based nucleotide insertion and primer extension assays have been
identified (6, 11, 20, 21, 24, 31). These include the
multi-dideoxynucleoside triphosphate-resistant E89G and the
3TC-resistant M184V RT variants. The M184V mutation arises in patients
in response to antiviral therapy with (
)2',3' dideoxy-3'-thiacytidine
(3TC; lamivudine) (27) and confers up to a 1,000-fold
increase in viral resistance to 3TC (7, 26, 30) as well as a
low-level cross-resistance to ddC and ddI (8). The E89G
mutation, initially isolated via a phenotypic bacterial screening assay
(22), confers a broad cross-resistance to deoxynucleotide (dNTP) analogs including ddATP, ddCTP, ddGTP, ddTTP, 3TCTP, and phosphonoformic acid (foscarnet; foscavir). This mutation has also been
observed in in vitro-selected, 3TC-resistant variants of HIV-1
(7). The influence of these mutations on drug sensitivity is
thought to be due to changes in the geometry of the dNTP-binding pocket
brought about by direct interaction of the altered residue with the
incoming dNTP in the case of M184V (12, 21, 29) or via
template repositioning in the case of E89G (4, 29).
Previous observations showing that E89G and M184V RTs display increased
fidelity of dNTP insertion and mispair extension suggested that these
enzymes may be less prone to polymerase errors that lead to base
substitution mutations. However, polymerase errors that contribute to
mutation rates are not limited to uncorrected polymerase misinsertions.
Both base substitutions and frameshift errors can be generated through
mechanisms not involving direct misinsertion but rather involving
template-primer slippage or dislocation (16, 28). In fact, a
large proportion of errors by HIV-1 RT have been shown to be of this
type (2). Thus, fidelities of dNTP insertion and mispair
extension cannot solely be used to determine an overall polymerase
error rate.
In this communication, we report the overall polymerase error rates of
the RT mutants E89G and M184V measured via an M13-based forward
mutation assay (2, 3). The double mutant E89G/M184V was also
included in the study to examine if the effects of the two mutations on
the overall error rate would be cumulative. Our findings indicate that
the overall levels of polymerase fidelity of wild-type, E89G, M184V,
and E89G/M184V HIV-1 RTs are similar (less than twofold differences).
However, the mutational spectra of the variant enzymes revealed altered
error specificities. It is unclear what impact such changes will have
on viral variation, and this remains to be experimentally examined.
 |
MATERIALS AND METHODS |
Phage DNA and bacterial strains.
Bacteriophage M13mp2, a
strain that carries the lacZ
gene of Escherichia
coli, was used to prepare gapped duplex DNA substrate. E. coli NR9099 [
(pro-lac) thi ara recA56/F'
(proAB lacIq Z
M15)] served as the bacterial
host for the preparation of both single-stranded and replicative-form
M13 DNA. Electrocompetent E. coli MC1061 [hsdR
hsdM+ araD
(ara leu)
(lacIPOZY) galU galK strA] cells were used to produce phage from the products of the fill-in reactions. E. coli CSH50 [
(pro-lac) thi ara strA/F'
(proAB lacIq Z
M15 traD36)] was
the
-complementation strain used to score mutant phage.
Enzymes.
Recombinant wild-type heterodimeric RT derived from
HIV-1Hxb2 and its variants with E89G, M184V, and E89G/M184V
substitutions were bacterially expressed from derivatives of plasmid
pL6H-PROT (14). The construction of these derivatives is
described elsewhere (10). The recombinant enzymes were
purified by Ni2+-nitrilotriacetic acid-hexahistidine
chromatography followed by DEAE- and S-Sepharose chromatography as
described earlier (15). The purified wild-type, E89G, M184V,
and E89G/M184V RTs had specific activities of 220, 680, 280, and 89 U/mg, respectively, and were found to be nuclease free (data not
shown). One unit is defined as the amount of enzyme required to
incorporate 1 nmol of dTMP into DNA on a poly(rA)-oligo(dT)
template-primer at 37°C in 10 min.
Forward mutation assay.
Gapped duplex M13mp2 DNA was
prepared as described previously (3) as the template for DNA
fill-in synthesis reactions. This template contained a single-stranded
region of 361 nucleotides including the upstream regulatory sequences
and the first 107 coding nucleotides of the lacZ
gene.
Gap-filling synthesis reactions were performed by combining purified RT
(0.07 to 0.45 U) with gapped duplex DNA (75 ng) in a reaction buffer
containing 75 mM Tris-Cl (pH 8.0), 80 mM KCl, 6 mM MgCl2,
10 mM dithiothreitol, and 500 µM each dATP, dCTP, dGTP, and dTTP
(Boehringer Mannheim, Indianapolis, Ind.) in a total volume of 25 µl,
and incubation for 1 h at 37°C. Complete gap closure was
confirmed via agarose gel electrophoresis.
Polymerization products were electroporated into E. coli
MC1061 host cells. After a brief (10-min) recovery period,
transformants were plated on a bacterial indicator lawn (CSH50) in the
presence of 0.195 mM
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal; Labscientific Inc., Livingston, N.J.) to generate plaques from released
phages. Following incubation for approximately 15 h at 37°C,
plaques were scored for
-complementation phenotype. Plaques produced
from phage with unmutated lacZ
gene display wild-type
complementation, efficiently hydrolyzing the chromogenic X-Gal substrate to appear dark blue. Mutant phage containing
lacZ
target mutations generate plaques whose phenotypes
range from nearly wild-type dark blue to colorless. Plaques of phage
designated as mutant were removed from initial screening plates and
placed in 0.9% NaCl (1 ml). Mutant phenotypes were confirmed by
plating equal inputs of wild-type and putative mutant phage (from
diffused 1 ml of stock) on an indicator lawn as described above for
initial screening. Once confirmed, mutant plaques were picked and
stored at 4°C in 0.9% NaCl (1 ml) until needed for sequence
analysis.
Mutational specificity.
Single-stranded phage DNA was
prepared as the template for sequence analysis as previously described
(3). DNA sequencing reactions were performed with a
Sequenase 2.0 DNA sequencing kit (Amersham Life Sciences, Arlington
Heights, Ill.) with the oligonucleotide 5'GCGCAGCTGTTGGGAAGGGCG3'
as primer. Sequencing reaction products were resolved on 6%
denaturing polyacrylamide gels by using a GENOMYXLR DNA
sequencer.
Calculating error frequencies and error rates.
Error
frequencies were calculated as the ratio of confirmed mutant plaques to
the total plaques screened. Spontaneous background mutation frequency
was determined by electroporating uncopied gapped DNA and scoring for
mutants as with DNA synthesized by RT. Corrected frequencies were then
obtained by subtracting the spontaneous background from the frequency
observed for a given RT (3).
Specific error rates were derived by multiplying the corrected overall
error frequency with the percentage, in the total mutations,
of the
particular class of errors being examined (e.g., frameshifts).
This
value was then divided by 0.6 (the likelihood of expression
of the
newly synthesized phage minus strand in
E. coli
[
17])
and then divided by the total number of sites
that are susceptible
to the given class of errors (
3).
Comparative statistical analysis
of hotspot error rates was performed
by using Fisher's exact test.
 |
RESULTS |
Overall mutation frequencies.
The fidelity of DNA synthesis by
wild-type, E89G, M184V, and E89G/M184V HIV-1 RTs was measured in an M13
phage gap-filling assay. Copying errors resulting in altered function
of the phage lacZ
reporter gene were phenotypically
scored. Gap-filling DNA synthesis reactions (two independent syntheses
per enzyme) were performed with purified wild-type, E89G, M184V, and
E89G/M184V HIV-1 RTs, and completion of the reaction was confirmed via
agarose gel electrophoresis (data not shown). M13 DNA was
electroporated into host E. coli, and plaques were generated
by plating the transformants on a bacterial indicator lawn. Mutation
frequencies for each enzyme were compiled from ratios of total mutant
to total wild-type plaques obtained from one to three electroporations
per gap-filling reaction per enzyme. The observed mutation frequencies
for the wild-type, E89G, M184V, and E89G/M184V HIV-1 RTs were 8.60 × 10
3, 6.26 × 10
3, 5.53 × 10
3, and 12.30 × 10
3, respectively
(Table 1). These represent
background-corrected values, adjusted by using the spontaneous mutation
frequency of uncopied gapped DNA of 1.5 × 10
3.
These results indicated that in terms of overall polymerase fidelity,
the wild-type, E89G, M184V, and E89G/M184V HIV-1 RTs exhibit similar
levels of fidelity (less than twofold differences). Of these, the E89G
and M184V RTs were slightly less error prone than wild-type RT, while
the E89G/M184V double mutant was slightly more error prone than
wild-type RT.
Analysis of mutation spectra of the variant RTs.
DNA sequence
analysis of the phage mutants generated by the individual RTs revealed
significant differences in the distribution and specificity of the
mutations induced (Fig.
1).
Mutations induced by wild-type, E89G, and M184V RTs
were fairly well distributed throughout the target region, with some
clustering at hotspots (sites with at least five mutations), while
those produced by E89G/M184V RT were almost exclusively clustered at
hotspots (see below). Close inspection of hotspot distribution shows
that certain hotspots are shared by all RTs (Table
2). For example, the base substitution
hotspot at position
36 is well represented in the spectra of all of
the RTs studied here, as is the frameshift hotspot at positions 137 to
139 (Fig. 1; Table 2). In contrast, the base substitution hotspot
observed in the mutation spectrum of wild-type RT at position 112 and
the deletion hotspot at positions 106 to 108 (Fig. 1) are conspicuously
absent from the spectra of the mutant RTs. In fact, with the mutant
RTs, these sites are nearly devoid of mutations (Fig. 1). Similarly,
the frameshift hotspot found at positions
34 to
36 in the spectra
of the E89G and E89G/M184V RTs is completely absent in the spectra of
wild-type and M184V RTs (P < 0.0001 for both E89G
[versus wild-type and M184V RTs] and E89G/M184V [versus wild-type
and M184V RTs]) (Fig. 1). Furthermore, a greater percentage of total
mutations induced by E89G/M184V (83.8%) are within hotspots compared
to mutations induced by the other RTs (wild type, 53.6%
[P < 0.0001]; E89G, 60.2% [P = 0.0002]; M184V, 60.6% [P = 0.0003]). For the
E89G/M184V variant, four sites (positions
36,
34 to
36, 70 to 73, and 137 to 139) account for almost 84% (83/99) of all mutations, with
the
34 to
36 positions alone accounting for 68% (67/99) of total
mutations observed (Fig. 1c; Table 2).

View larger version (105K):
[in this window]
[in a new window]

View larger version (110K):
[in this window]
[in a new window]

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 1.
(a) Spectrum of mutations induced by wild-type HIV-1 RT
and its E89G variant. Comparison of mutations generated in the
lacZ target by wild-type HIV-1Hxb2 and E89G
HIV-1 RTs is shown. Mutations induced by wild-type
HIV-1Hxb2 RT are represented above the template sequence
(white), and mutations induced by E89G HIV-1 RT are shown below the
template sequence. Substitutions are indicated by the letter
corresponding to the new base (in yellow) above or below the base in
the template sequence it is replacing. Nucleotide deletions are
indicated by an upright (red) triangle over or under the corresponding
run of template bases; nucleotide additions are indicated by an
inverted (red) triangle over or under the corresponding run of template
bases. Triangles with numerals (2 or 3) underneath them indicate
deletions involving more than one base (the bases deleted or are
thought to be involved in the deletion are underlined in red). A
two-base deletion with the asterisk indicates where it was not possible
to determine whether bases 140 and 141 or 141 and 142 were deleted.
Nucleotide positions are indicated below the template sequence. (b)
Spectrum of mutations induced by wild-type and the M184V mutant HIV-1
RTs. Comparison of mutations generated in the lacZ target
by wild-type HIV-1Hxb2 and M184V HIV-1 RTs is shown.
Mutations induced by wild-type HIV-1Hxb2 RT are represented
above the template sequence (white), and mutations induced by M184V
HIV-1 RT are shown below the template sequence. (c) Spectrum of
mutations induced by wild-type and E89G/M184V mutant RTs. Comparison of
mutations generated in the lacZ target by wild-type
HIV-1Hxb2 and E89G/M184V HIV-1 RTs is shown. Mutations
induced by wild-type HIV-1Hxb2 RT are represented above the
template sequence (white), and mutations induced by E89G/M184V HIV-1 RT
are shown below the template sequence.
|
|
Sequence analysis also revealed that wild-type and M184V RTs generated
predominantly base substitution mutations, roughly
75% (103/138) and
77% (80/104), respectively, of all mutations
(Table
3). On the other hand, E89G RT generated
substitution
and frameshift mutations (mainly single-base deletions) at
almost
equal proportions (57:51) (Table
3). Interestingly, the
E89G/M184V
double mutant had a phenotype intermediate to that of single
mutants
with respect to base substitution/frameshift ratio, with
approximately
67% (66/99) of RT-induced mutations being of the
substitution
class (Table
3).
Most of the frameshift mutations detected involved the gain (+1) or
loss (

1) of one base. Frameshift mutations involving
the deletion of
two bases were seen only with E89G (four occurrences
out of 51 frameshift mutations; Fig.
1a) and E89G/M184V RTs (one
occurrence out
of 33 frameshifts; Fig.
1c). Frameshift mutations
generated by E89G
also included one deletion involving three bases
(Fig.
1a). Major
deletions (>50 bp) were also induced; however,
they were uncommon and
seen only with wild-type (2 of 138 mutants
scored) and E89G (3 of 108 mutants scored) RTs.
 |
DISCUSSION |
Viral mutation rates are the products of the combined effects of
overall polymerase (copying) error rates, replication rates, and
biological selection (5). Presumably, increases or decreases in any of these factors could result in corresponding changes in
mutation rate. This notion has previously not been tested for any
variant of HIV-1 RT. The variants of HIV-1 RT that were recently reported to possess increased fidelities of dNTP insertion and primer
extension in in vitro assays (6, 11, 20, 21, 24, 31)
appeared suitable to examining the contributions of polymerase fidelity
to overall mutation rate in vivo. Thus, we have determined the overall
copying fidelity of the E89G, M184V, and E89G/M184V RT variants. We had
earlier reported increases of three- to sixfold in average nucleotide
insertion fidelity for the M184V and E89G RTs (6, 31). When
changes in the fidelity of formation of specific mispairs are
considered, the increases of 2- to 45-fold (6, 21, 24, 31)
have been seen. With respect to terminal mismatch extension efficiency,
increases in fidelity of primer extension, ranging from 3- to 66-fold
greater (for extension from specific mispairs) than for wild-type RT,
have been reported for E89G and M184V RTs (11, 20, 24). In
contrast to these large increases in fidelities of dNTP insertion and
primer extension previously observed for specific types of errors, the
M184V and E89G RTs in the current study showed only slightly decreased
overall polymerase error rates whereas the E89G/M184V variant rate was slightly increased (less than twofold differences when compared to the
wild type) (Table 1). This discrepancy could be a result of the
influence of certain features of the M13 forward mutation assay, such
as host repair and the ability to detect slippage-mediated errors in
addition to nucleotide misinsertion and mispair extension. In fact, a
substantial proportion of the total mutations observed occurred within
the homonucleotide runs in the template sequence which are primary
sites for slippage-mediated mutagenesis. Thus, in light of the modest
differences observed in overall error rates, it appears that any
increases in fidelity of these mutants that may be afforded by the
increased dNTP insertion/primer extension fidelity are muted by the
contributions of other mutagenic mechanisms.
The lack of increase in fidelity for M184V RT seen in this study would
appear to be concordant with the biological data regarding viral
evolution of M184V mutant viruses. Drug-resistant variants of such
viruses were found to emerge in cell culture at rates equal to those of
wild-type viruses (1, 13), suggesting that mutation rates
were unaffected by the RT mutation. It is likely that compensatory
factors similar to those operating in the M13 forward assay (as
described above) were modulating the effect of the viral 184V
substitution.
Although both E89G and M184V mutations increase nucleotide
insertion/primer extension fidelity, it seems likely that they exert
their effects via distinct mechanisms. The residues affected by these
mutations lie within the enzyme active site in or near the dNTP-binding
pocket (12, 29). Structural data place these residues at
opposing sides of the active site, with the E89 residue contacting the
phosphate-deoxyribose backbone of the template strand and the M184
residue interacting with the sugar moiety of the primer terminus
(12, 29). Consequently, as mutations at these residues alter
different surfaces of the dNTP-binding pocket, it might be anticipated
that the effects of these modifications on the dNTP-binding pocket
conformation would differ. Such differences are reflected in the
divergence seen in the distribution and specificity of mutations
induced by the variants. For instance, the E89G mutation had an
enhancing effect on frameshift mutagenesis (both run and non-run
associated). In contrast, the M184V mutation had a minimal effect on
this class of errors (Table 3). It is generally thought that most
frameshift mutations (insertions and deletions) involving few (one to
three) nucleotides arise from transiently misaligned or slipped
template-primer intermediates (28). The E89 residue is
located within the
5a strand of the palm region of RT, where it is
thought to help the polymerase grip the template (12). It is
conceivable that the glycine substitution at this residue, by virtue of
glycine's smaller side chain, results in a looser grip, which might
enable the primed template to more easily form misaligned intermediates
while still bound to the enzyme. Alternatively, a looser template grip
stemming from the 89G mutation might allow the RT to more readily
dissociate from the template, providing greater opportunity for the
formation of misaligned template-primers. A determination of
dissociation rates using purified RTs and model template-primers may
help differentiate between the two possibilities. The M184 residue
participates in dNTP binding (21, 32) rather than
template-primer grip. Thus, it is possible that substitutions at this
position affect utilization of frameshift intermediates rather than the
enzyme's ability to promote their formation.
To date, the E89G substitution has been found only in viral isolates
bearing the M184V mutation as well. Therefore, the E89G/M184V double
mutant was studied in order to understand the cumulative effect of
these two mutations on error rate. Curiously, when present independently, the individual mutations increased polymerase fidelity slightly while a combination of the two led to a slight decrease in the
overall polymerase fidelity (Table 1). More unexpected was the highly
clustered distribution of the mutations induced by the E89G/M184V RT,
considering that both E89G and M184V RTs generated mutations that were
fairly well distributed. Yet the influence of both RT mutations appears
to be seen in the mutational specificity of the double mutant. Hotspots
common to both single variants (positions
36 and 137 to 139) are
reproduced by the E89G/M184V variant. The strong representation of the
deletion hotspot at the
34 to
36 site seems to suggest some
dominance of the 89G mutation; however, the lack of non-run-associated
frameshifts for the double mutant appears to indicate a significant
contribution by the 184V residue to frameshift specificity. Thus, the
error specificities of each single mutation are preserved to a degree in the double mutant while the effects of each individual substitution on polymerase fidelity are somewhat modulated by the other. Since these
two residues occupy opposite sides of the active site, it may be
possible that steric constraints imposed by these substitutions are
additive, thus further restricting the range of stable premutational intermediates. If this is so, it may offer an explanation for the
limited mutation distribution exhibited by E89G/M184V RT.
Since the influence of these mutations on overall RT fidelity appears
minimal, could differences in error specificity have a significant
biological effect on viruses harboring these mutations? It is difficult
to predict any specific effects of 184V alteration since the change
observed in overall fidelity was small. In the case of E89G variant
viruses, perhaps the enhancement in frameshift mutagenesis associated
with the 89G substitution when expressed in vivo results in a higher
proportion of virions with single-base insertions and deletions which
are far more likely to be lethal than base substitutions. This may
partially account for the failure of this mutation to be seen in a
viral isolate independent of the 184V substitution. The ability of the
M184V mutation to reduce the frameshift mutagenicity of E89G could
permit a variant HIV with both mutations to replicate and to be
recovered via in vitro selection protocols (7).
Finally, it is known that sequence context contributes substantially to
the mutagenic potential of a given nucleotide site (2, 18,
23), and this likely results in the site bias that produces
hotspots. The studies reported here were conducted in the context of
the lacZ
gene, which may not be representative of viral
sequences. Therefore, these RT mutations could impart to replicating
viral genomes overall fidelities higher or lower than those observed
here. In this context, the double mutant E89G/M184V RT in particular
needs to be tested for its effect on viral mutation rate since it
appears to display few mutations outside the hotspots which are so
characteristic of lacZ
gene. It should be possible through single-cycle infection studies with HIVs containing these mutations to establish the in vivo significance of our findings.
 |
ACKNOWLEDGMENTS |
We thank Clyde A. Hutchison III (University of North Carolina,
Chapel Hill) for providing phasmids of the M184V mutant RT cDNA,
B. D. Preston for providing the M13mp2 phage, T. A. Kunkel (National Institute for Environmental Health Sciences) for providing the bacterial strains for the M13 forward mutation assay, Kenneth Curr,
Clark Choi, and Jayanthi Manne for technical assistance, Ganjam V. Kalpana, William Franklin, and Lisa Rezende for critically reading the
manuscript, and the Oligonucleotide Synthesis Facility of the Albert
Einstein College of Medicine's Cancer Center for DNA oligonucleotides.
This work was supported by Public Health Service grants AI-30861 and
AI-40375 (to V.R.P.). W.C.D. acknowledges support from institutional
training grant T32-AI07501.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2517. Fax: (718)
430-8976. E-mail: prasad{at}aecom.yu.edu.
 |
REFERENCES |
| 1.
|
Balzarini, J.,
H. Pelemans,
A. Karlsson,
E. De Clercq, and J. P. Kleim.
1996.
Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors.
Proc. Natl. Acad. Sci. USA
93:13152-13157[Abstract/Free Full Text].
|
| 2.
|
Bebenek, K.,
J. Abbotts,
J. D. Roberts,
S. H. Wilson, and T. A. Kunkel.
1989.
Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase.
J. Biol. Chem.
264:16948-16956[Abstract/Free Full Text].
|
| 3.
|
Bebenek, K., and T. A. Kunkel.
1995.
Analyzing fidelity of DNA polymerases.
Methods Enzymol.
262:217-232[Medline].
|
| 4.
|
Boyer, P. L.,
C. Tantillo,
A. Jacobo-Molina,
R. G. Nanni,
J. Ding,
E. Arnold, and S. H. Hughes.
1994.
Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.
Proc. Natl. Acad. Sci. USA
91:4882-4886[Abstract/Free Full Text].
|
| 5.
|
Coffin, J.
1996.
HIV viral dynamics.
AIDS
10:S75-S84.
|
| 6.
|
Drosopoulos, W. C., and V. R. Prasad.
1996.
Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase.
J. Virol.
70:4834-4838[Abstract].
|
| 7.
|
Gao, Q.,
Z. Gu,
M. A. Parniak,
J. Cameron,
N. Cammack,
C. Boucher, and M. A. Wainberg.
1993.
The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the ( ) enantiomer of 2',3'-dideoxy-3'-thiacytidine.
Antimicrob. Agents Chemother.
37:1390-1392[Abstract/Free Full Text].
|
| 8.
|
Gu, Z.,
Q. Gao,
X. Li,
M. A. Parniak, and M. A. Wainberg.
1992.
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
J. Virol.
66:7128-7135[Abstract/Free Full Text].
|
| 9.
|
Hahn, B. H.,
G. M. Shaw,
M. E. Taylor,
R. R. Redfield,
P. D. Markham,
S. Z. Salahuddin,
F. Wong-Staal,
R. C. Gallo,
E. S. Parks, and W. P. Parks.
1986.
Genetic variation in HTLV III/LAV over time in patients with AIDS or at risk for AIDS.
Science
232:1548-1553[Abstract/Free Full Text].
|
| 10.
| Hamburgh, M. E., W. C. Drosopoulos, and
V. R. Prasad. The influence of 3TC-resistance mutations M184V
and E89G in the human immunodeficiency virus reverse transcriptase on
mispair extension efficiency. Submitted for publication.
|
| 11.
|
Hsu, M.,
P. Inouye,
L. Rezende,
N. Richard,
Z. Li,
V. R. Prasad, and M. A. Wainberg.
1997.
Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild type reverse transcriptase of human immunodeficiency virus type 1.
Nucleic Acids Res.
25:4532-4536[Abstract/Free Full Text].
|
| 12.
|
Jacobo-Molina, A.,
J. Ding,
R. G. Nanni,
A. D. J. Clark,
X. Lu,
C. Tantillo,
R. L. Williams,
G. Kamer,
A. L. Ferris,
P. Clark,
A. Hizi,
S. Hughes, and E. Arnold.
1993.
Crystal structure of human immunodeficiency virus reverse transcriptase complexed with double stranded DNA at 3.0 Å resolution shows bent DNA.
Proc. Natl. Acad. Sci. USA
90:6320-6324[Abstract/Free Full Text].
|
| 13.
|
Keulen, W.,
M. Nijhuis,
R. Schuurman,
B. Berkhout, and C. Boucher.
1997.
Reverse transcriptase and HIV variation.
Science
275:229. (Comment.)
|
| 14.
| Kew, Y., L. Olsen, A. Japour, and V. R. Prasad. Insertions into the b3-b4 hairpin loop of HIV-1 reverse
transcriptase reveal a role for fingers subdomain in processive
polymerization. J. Biol. Chem., in press.
|
| 15.
|
Kew, Y.,
Q. Song, and V. Prasad.
1994.
Subunit selective mutagenesis of Glu89 residue in human immunodeficiency virus reverse transcriptase.
J. Biol. Chem.
269:15331-15336[Abstract/Free Full Text].
|
| 16.
|
Kunkel, T. A., and P. S. Alexander.
1986.
The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation.
J. Biol. Chem.
261:160-166[Abstract/Free Full Text].
|
| 17.
|
Kunkel, T. A., and A. Soni.
1988.
Exonucleolytic proofreading enhances the fidelity of DNA synthesis by chick embryo DNA polymerase-gamma.
J. Biol. Chem.
263:4450-4459[Abstract/Free Full Text].
|
| 18.
|
Mendelman, L. V.,
M. S. Boosalis,
J. Petruska, and M. F. Goodman.
1989.
Nearest neighbor influences on DNA polymerase insertion fidelity.
J. Biol. Chem.
264:14415-14423[Abstract/Free Full Text].
|
| 19.
|
Meyerhans, A.,
R. Cheynier,
J. Albert,
M. Seth,
S. Kwok,
J. Sninsky,
L. Morfeldt-Manson,
B. Asjo, and S. Wain-Hobson.
1989.
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.
Cell
58:901-910[Medline].
|
| 20.
|
Oude Essink, B. B.,
N. K. T. Back, and B. Berkhout.
1997.
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.
Nucleic Acids Res.
25:3212[Abstract/Free Full Text].
|
| 21.
|
Pandey, V. N.,
N. Kaushik,
N. Rege,
S. G. Sarafianos,
P. N. S. Yadav, and M. J. Modak.
1996.
Role of methionine 184 in human immunodeficiency virus type 1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis.
Biochemistry
35:2168-2179[Medline].
|
| 22.
|
Prasad, V. R.,
I. Lowy,
T. De Los Santos,
L. Chiang, and S. P. Goff.
1991.
Isolation and characterization of a dideoxyguanosine triphosphate-resistant HIV-1 reverse transcriptase expressed in bacteria.
Proc. Natl. Acad. Sci. USA
88:11363-11367[Abstract/Free Full Text].
|
| 23.
|
Ricchetti, M., and H. Buc.
1990.
Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent.
EMBO J.
9:1583-1593[Medline].
|
| 24.
|
Rubinek, T.,
M. Bakhanashvili, and A. Hizi.
1997.
The fidelity of 3' misinsertion and mispair extension during DNA synthesis exhibited by two drug-resistant mutants of the reverse transcriptase of human immunodeficiency virus type 1 with Leu74Val and Glu89Gly.
Eur. J. Biochem.
247:238[Medline].
|
| 25.
|
Saag, M. S.,
B. H. Hahn,
J. Gibbons,
Y. Li,
E. S. Parks,
W. P. Parks, and G. M. Shaw.
1988.
Extensive variation of human immunodeficiency virus type-1 in vivo.
Nature
334:440-444[Medline].
|
| 26.
|
Schinazi, R. F.,
R. M. Lloyd, Jr.,
M. Nguyen,
D. L. Cannon,
A. McMillan,
N. Ilksoy,
C. K. Chu,
D. C. Liotta,
H. Z. Bazmi, and J. W. Mellors.
1993.
Characterization of human immunodeficiency viruses resistant to Oxathiolane-cytosine nucleosides.
Antimicrob. Agents Chemother.
37:875-881[Abstract/Free Full Text].
|
| 27.
|
Schuurman, R.,
M. Nijhuis,
R. van Leeuwen,
P. Schipper,
D. de Jong,
P. Collis,
S. A. Danner,
J. Mulder,
C. Loveday, and C. Christopherson.
1995.
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).
J. Infect. Dis.
171:1411-1419[Medline].
|
| 28.
|
Streisinger, G.,
Y. Okada,
J. Emrich,
J. Newton,
A. Tsugita,
E. Terzaghi, and M. Inouye.
1966.
Frameshift mutations and the genetic code.
Cold Spring Harbor Symp. Quant. Biol.
31:77-84[Abstract/Free Full Text].
|
| 29.
|
Tantillo, C.,
J. Ding,
A. Jacobo-Molina,
R. G. Nanni,
P. L. Boyer,
S. H. Hughes,
R. Pauwels,
K. Andries,
P. A. Janssen, and E. Arnold.
1994.
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
J. Mol. Biol.
243:369-387[Medline].
|
| 30.
|
Tisdale, M.,
S. D. Kemp,
N. R. Parry, and B. A. Larder.
1993.
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Proc. Natl. Acad. Sci. USA
90:5653-5656[Abstract/Free Full Text].
|
| 31.
|
Wainberg, M. A.,
W. C. Drosopoulos,
H. Salomon,
M. Hsu,
G. Borkow,
M. Parniak,
Z. Gu,
Q. Song,
J. Manne,
S. Islam,
G. Castriota, and V. R. Prasad.
1996.
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.
Science
271:1282-1285[Abstract].
|
| 32.
|
Wilson, J. E.,
A. Aulabaugh,
B. Caligan,
S. McPherson,
J. K. Wakefield,
S. Jablonski,
C. D. Morrow,
J. E. Reardon, and P. A. Furman.
1996.
Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met-184 to binding of nucleoside 5'-triphosphate.
J. Biol. Chem.
271:13656-13662[Abstract/Free Full Text].
|
J Virol, May 1998, p. 4224-4230, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hamburgh, M. E., Curr, K. A., Monaghan, M., Rao, V. R., Tripathi, S., Preston, B. D., Sarafianos, S., Arnold, E., Darden, T., Prasad, V. R.
(2006). Structural Determinants of Slippage-mediated Mutations by Human Immunodeficiency Virus Type 1 Reverse Transcriptase. J. Biol. Chem.
281: 7421-7428
[Abstract]
[Full Text]
-
Curr, K., Tripathi, S., Lennerstrand, J., Larder, B. A., Prasad, V. R.
(2006). Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro. J. Gen. Virol.
87: 419-428
[Abstract]
[Full Text]
-
Skasko, M., Weiss, K. K., Reynolds, H. M., Jamburuthugoda, V., Lee, K., Kim, B.
(2005). Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases. J. Biol. Chem.
280: 12190-12200
[Abstract]
[Full Text]
-
Nikolenko, G. N., Svarovskaia, E. S., Delviks, K. A., Pathak, V. K.
(2004). Antiretroviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Template-Switching Frequency. J. Virol.
78: 8761-8770
[Abstract]
[Full Text]
-
Sharma, B., Kaushik, N., Upadhyay, A., Tripathi, S., Singh, K., Pandey, V. N.
(2003). A positively charged side chain at position 154 on the {beta}8-{alpha}E loop of HIV-1 RT is required for stable ternary complex formation. Nucleic Acids Res
31: 5167-5174
[Abstract]
[Full Text]
-
Pfeiffer, J. K., Kirkegaard, K.
(2003). A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. USA
100: 7289-7294
[Abstract]
[Full Text]
-
Fisher, T. S., Darden, T., Prasad, V. R.
(2003). Mutations Proximal to the Minor Groove-Binding Track of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Differentially Affect Utilization of RNA versus DNA as Template. J. Virol.
77: 5837-5845
[Abstract]
[Full Text]
-
Mansky, L. M., Le Rouzic, E., Benichou, S., Gajary, L. C.
(2003). Influence of Reverse Transcriptase Variants, Drugs, and Vpr on Human Immunodeficiency Virus Type 1 Mutant Frequencies. J. Virol.
77: 2071-2080
[Abstract]
[Full Text]
-
Murry, J. P., Higgins, J., Matthews, T. B., Huang, V. Y., Van Rompay, K. K. A., Pedersen, N. C., North, T. W.
(2002). Reversion of the M184V Mutation in Simian Immunodeficiency Virus Reverse Transcriptase Is Selected by Tenofovir, Even in the Presence of Lamivudine. J. Virol.
77: 1120-1130
[Abstract]
[Full Text]
-
Zhang, W.-H., Svarovskaia, E. S., Barr, R., Pathak, V. K.
(2002). Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc. Natl. Acad. Sci. USA
99: 10090-10095
[Abstract]
[Full Text]
-
Fisher, T. S., Prasad, V. R.
(2002). Substitutions of Phe61 Located in the Vicinity of Template 5'-Overhang Influence Polymerase Fidelity and Nucleoside Analog Sensitivity of HIV-1 Reverse Transcriptase. J. Biol. Chem.
277: 22345-22352
[Abstract]
[Full Text]
-
Shafer, R. W.
(2002). Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance. Clin. Microbiol. Rev.
15: 247-277
[Abstract]
[Full Text]
-
Gutierrez-Rivas, M., Menendez-Arias, L.
(2001). A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis. Nucleic Acids Res
29: 4963-4972
[Abstract]
[Full Text]
-
Mansky, L. M., Bernard, L. C.
(2000). 3'-Azido-3'-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1. J. Virol.
74: 9532-9539
[Abstract]
[Full Text]
-
Boyer, P. L., Hughes, S. H.
(2000). Effects of Amino Acid Substitutions at Position 115 on the Fidelity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. J. Virol.
74: 6494-6500
[Abstract]
[Full Text]
-
Halvas, E. K., Svarovskaia, E. S., Pathak, V. K.
(2000). Development of an In Vivo Assay To Identify Structural Determinants in Murine Leukemia Virus Reverse Transcriptase Important for Fidelity. J. Virol.
74: 312-319
[Abstract]
[Full Text]
-
Wisniewski, M., Palaniappan, C., Fu, Z., Le Grice, S. F. J., Fay, P., Bambara, R. A.
(1999). Mutations in the Primer Grip Region of HIV Reverse Transcriptase Can Increase Replication Fidelity. J. Biol. Chem.
274: 28175-28184
[Abstract]
[Full Text]
-
Shah, F. S., Curr, K. A., Hamburgh, M. E., Parniak, M., Mitsuya, H., Arnez, J. G., Prasad, V. R.
(2000). Differential Influence of Nucleoside Analog-resistance Mutations K65R and L74V on the Overall Mutation Rate and Error Specificity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. J. Biol. Chem.
275: 27037-27044
[Abstract]
[Full Text]
-
Diamond, T. L., Kimata, J., Kim, B.
(2001). Identification of a Simian Immunodeficiency Virus Reverse Transcriptase Variant with Enhanced Replicational Fidelity in the Late Stage of Viral Infection. J. Biol. Chem.
276: 23624-23631
[Abstract]
[Full Text]